Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach

Using a yeast-based approach to screen a library of xanthones selected by docking, the pyranoxanthone was identified as p53-MDM2 inhibitor, which activated p53 and downstream signaling in human tumor cells.